Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
MAINSTAY MACKAY DEFINEDTERM MUNICIPAL OPPORTUNITIES FUND	MMD	Nyse	63,169	16.32 USD	Stock
IQ MACKAY MULTI-SECTOR INCOME ETF - USD	MMSB	Nyse	-	- USD	ETF
IQ MACKAY ESG HIGH INCOME ETF - USD	IQHI	Nyse	41	26.2 USD	ETF
IQ MACKAY CALIFORNIA MUNICIPAL INTERMEDIATE ETF - USD	MMCA	Nyse	3,550	21.55 USD	ETF
IQ MACKAY ESG CORE PLUS BOND ETF - USD	ESGB	Nyse	913	20.66 USD	ETF

News (1100)

Schroders : 2024 AGM Statement from Chair and Group Chief Executive	05-02	PU
Schroders : 2024 AGM Voting Results	04-25	PU
Schroders : Proxy form (post)	03-22	PU
Schroders : Proxy form (deemed)	03-22	PU
Schroders : Notice of AGM 2024	03-22	PU
GSK : Governance and Remuneration report 2023	03-01	PU
Schroders plc Announces Directorate Change	02-29	CI
Primetime Property : UNCLAIMED DEBENTURE INTEREST	23-10-12	PU
National Grid plc Announces Director & Committee Changes	23-09-21	CI
National Grid : Notice of Meeting 2023	23-06-06	PU
National Grid : Form of Proxy 2023	23-06-06	PU
National Grid : 6 June 2023 - Notice of 2023 Annual General Meeting	23-06-06	PU
National Grid : 6 June 2023 - Notice of 2023 Annual General Meeting	23-05-25	PU
Schroders taps PwC exec as CFO, GSK CFO as non-exec director	23-04-27	AN
Schroders plc Appoints Iain Mackay as an Independent Non-Executive Director, Effective 1 January 2024	23-04-27	CI
Transcript : GSK plc, Q1 2023 Earnings Call, Apr 26, 2023	23-04-26
GSK : Q1 2023 results slides	23-04-26	PU
GSK : AGM Notice 2023	23-03-27	PU
GSK : Corporate governance report 2022	23-03-10	PU
GSK : FY 2022 results transcript	23-02-02	PU
Transcript : GSK plc, Q4 2022 Earnings Call, Feb 01, 2023	23-02-01
GSK : FY 2022 results slides	23-02-01	PU
Transcript : GSK plc Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 07:30 AM	23-01-10
National Grid plc Announces Board Changes	22-12-14	CI
GSK : Q3 2022 results transcript	22-11-03	PU
GSK : Supplementary Prospectus	22-11-03	PU
Transcript : GSK plc, Q3 2022 Earnings Call, Nov 02, 2022	22-11-02
GSK : Q3 2022 results slides	22-11-02	PU
GSK : 2022 Q3 pre-announcement aide memoire (PDF - 462.7KB)	22-10-14	PU
Iain Mackay, Chief Financial Officer, to retire from GSK, Julie Brown appointed as successor	22-09-27	AQ
FTSE 100 Closes Higher, Makes Up for Early Losses	22-09-26	DJ
GSK plc - Iain Mackay, Chief Financial Officer, to retire from GSK, Julie Brown appointed as successor	22-09-26	AQ
Pound's Fall Should Trigger a Response From the Bank of England	22-09-26	DJ
BOE Unlikely to Deliver Emergency Rate Rise as Pound Plunges, Says ING	22-09-26	DJ
FTSE 100 Falls Again as UK Fiscal Spending Plan Sparks Concerns	22-09-26	DJ
FTSE 100 gains as weak pound lifts export-heavy consumer staples	22-09-26	RE
FTSE 100 Seen Opening Higher as Pound Hits Record Low	22-09-26	DJ
GSK PLC Names Julie Brown as New CFO; Iain Mackay to Retire in May	22-09-26	DJ
GSK selects Burberry's Brown as its first female CFO	22-09-26	RE
GSK Appoints Julie Brown As CFO	22-09-26	RE
GSK Hires Julie Brown for Creating All-Female Top Team	22-09-26	CI
GSK plc Announces Executive Changes	22-09-26	CI
GSK plc Announces Executive Changes	22-09-26	CI
Sterling Parity Versus Dollar Looks Almost Certain, Says Swissquote	22-09-26	DJ
GSK to Appoint Julie Brown as Next Finance Chief, Sky Reports	22-09-26	DJ

1234NextSee all

Companies (19)

UNITED SPIRITS LIMITED 10 231 M $

United Spirits Limited is India's largest spirits producer. The group provides Scotch (Black Dog, Dalmore, Jura and White & Mackay brands), Whisky (Antiquity, Bagpiper, McDowell's No.1 and McDowell's No.1 Platinum), rhum (Celebration rum), vodka (Pinky, R ...

AGRIMIN LIMITED 54 M $

Agrimin Limited is an Australia-based fertilizer development company. The principal activity of Company includes advancing the Mackay Potash Project in Western Australia. It operates in the area of mineral exploration and development in Western Australia. ...

PRODIGY GOLD NL 4 M $

Prodigy Gold NL is an Australia-based company, which focuses on exploration and evaluation of mineral resources. The Company has a greenfield and brownfields exploration portfolio in the proven Tanami Gold Province. Its projects include the Lake Mackay Pr ...

MAINSTAY MACKAY DEFINEDTERM MUNICIPAL OPPORTUNITIES FUND 455 M $

MainStay MacKay DefinedTerm Municipal Opportunities Fund is a diversified closed-end management investment company. The Fund's primary investment objective is to seek current income exempt from regular United States (U.S.) federal income taxes (but which ...

SUGAR TERMINALS LIMITED 255 M $

Sugar Terminals Limited is an Australia-based company that provides sustainable, and storage and handling solutions for bulk sugar and other commodities. The Company owns and operates six bulk commodity terminals in Queensland, located at the ports of Cai ...

RIVERNORTH FLEXIBLE MUNICIPAL INCOME FUND II, INC. 338 M $

Rivernorth Flexible Municipal Income Fund II, Inc. is a diversified, closed-end management investment company. The Fundâs primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The Fundâs secondary invest ...

DALRYMPLE BAY INFRASTRUCTURE LIMITED 938 M $

Dalrymple Bay Infrastructure Limited is an Australia-based metallurgical coal export facility company. The Company provides port infrastructure and services for producers and consumers of Australian coal exports. The Company is engaged in the provision of ...

RIVERNORTH MANAGED DURATION MUNICIPAL INCOME FUND INC. 296 M $

RiverNorth Managed Duration Municipal Income Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fundâs primary investment objective is to seek current income exempt from regular United States federal income taxes. The ...

EXGEN RESOURCES INC. 3 M $

ExGen Resources Inc. is a Canada-based junior resource company. The Company is engaged in the exploration of copper-gold mineral properties in Canada and the United States. Its projects include Empire Mine Project, DOK Project, Gordon Lake, Boss Property ...

GBM RESOURCES LIMITED 7 M $

GBM Resources Limited is an Australia-based mineral exploration and development company focused on the discovery of gold and copper deposits in Eastern Australia. The Company has a project portfolio, hosting district scale mineral systems, located in a nu ...

12Next

Insiders

Iain Ruaraidh Mackay

Iain Mackay

Iain James Mackay occupies the position of Chief Financial Officer & Executive Director at GlaxoSmithKline Plc and Director & Finance Director at HSBC Holdings PLC (Hong Kong). He is also Court Member at the University of Aberdeen and Member of The Institute of Chartered Accountants of Scotland and on the board of 5 other companies.
He previously occupied the position of Executive Director & Group Finance Director at HSBC Holdings Plc Chief Financial Officer of The HongKong & Shanghai Banking Corp. Ltd. Chief Financial Officer at HSBC Asia Pacific Holdings (UK) Ltd. CFO & Senior Executive Vice President at HSBC Finance Corp. and Chief Financial Officer & Senior EVP at HSBC North America Holdings, Inc. (which are all subsidiaries of HSBC Holdings Plc), Finance Director-Europe, Africa & South East Asia at Dowell Schlumberger, Chief Financial Officer & Vice President for Global Life Sciences Solutions Manufacturing UK Ltd. and Chief Financial Officer & Vice President at GE Consumer Finance, Inc.
Mr. Mackay received a graduate degree from the University of Aberdeen.

MacKay

Iain

James Morrison MacKay

Julie Mackay

Hugh MacKay

Hugh MacKay served as a Non-Executive Director at Stewart Milne Group Ltd.
from 1975 to 2019.

Geoff MacKay

Geoff MacKay was the founder of Avrobio, Inc. (founded in 2015) where he held the title of President, Chief Executive Officer & Director until 2023.
He is also the founder of eGenesis, Inc. (founded in 2015) where he held the title of Chief Executive Officer & Director until 2017.
Currently, Mr. MacKay is the Chairman of Satellos Bioscience, Inc. since 2018 and a Director at RedactBio, Inc. His former positions include President & Chief Executive Officer at Organogenesis, Inc. from 2003 to 2014, Chief Executive Officer at Organogenesis, Inc., Chairman of Massachusetts Biotechnology Council, Chairman of Alliance for Regenerative Medicine, Chairman of Satellos Bioscience, Inc., Independent Director at RepliCel Life Sciences, Inc., Director at Centre For Commercialization of Regenerative Medicine, Independent Director at Talaris Therapeutics, Inc., Director at Gemstone Biotherapeutics LLC, and Vice President at Novartis AG.
Mr. MacKay also served as an Advisor at Atlas Venture Advisors, Inc. from 2015 to 2023.
He obtained his undergraduate degree from McGill University.

No results for this search